Video Experimental Relacionado
Updated: Dec 9, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
La inmunidad antitumoral controlada a través de la metilación del ARNm y el YTHDF1 en las células dendríticas
Dali Han1,2,3, Jun Liu4,5,6, Chuanyuan Chen7,8,9
1Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. handl@big.ac.cn.
Nature
|February 8, 2019
Resumen
La metilación del ARN mensajero (ARNm) N6 (m6A), regulada por el YTHDF1, controla la inmunidad antitumoral duradera. La deficiencia de YTHDF1 aumenta las respuestas de las células T CD8 y mejora la eficacia de la inmunoterapia.
Área de la Ciencia:
- Inmunología
- Biología molecular
- Investigación del cáncer
Sus antecedentes:
- Los neoantígenos tumorales son cruciales para la inmunidad antitumoral y la respuesta a la inmunoterapia.
- A pesar de la presencia de un neoantígeno, la eliminación completa del tumor a menudo está limitada por respuestas inmunes insuficientes.
Objetivo del estudio:
- Investigar el papel del ARNm N6 - metadenosina (m6A) metilación y YTHDF1 en la regulación de la inmunidad antitumoral.
- Explorar el impacto de YTHDF1 en la presentación del neoantígeno y las respuestas de las células T.
Principales métodos:
- Análisis comparativo de ratones con deficiencia de Ythdf1 y ratones salvajes.
- Evaluación de las respuestas de las células T CD8+ y la presentación cruzada de antígenos tumorales en células dendríticas.
- Investigación del mecanismo de YTHDF1 que involucra m6 transcripciones marcadas con A y catepsinas lisosómicas.
Principales resultados:
- Los ratones con deficiencia de Ythdf1 mostraron respuestas antitumorales mejoradas de células T CD8+ específicas del antígeno.
- La pérdida de YTHDF1 en las células dendríticas mejoró la presentación cruzada de antígenos tumorales y la iniciación cruzada de células T.
- YTHDF1 se une a m6 transcripciones marcadas por A, aumentando la traducción de catepsina e inhibiendo la presentación cruzada de antígenos.
Conclusiones:
- YTHDF1 regula la inmunidad duradera específica del neoantígeno a través de la metilación m6A.
- La orientación a YTHDF1 mejora las respuestas de las células T CD8+ antitumorales y la eficacia de la inmunoterapia PD-L1.
- YTHDF1 representa un objetivo terapéutico potencial para mejorar la inmunoterapia contra el cáncer.
Videos de Conceptos Relacionados
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:46Epigenetic Regulation
33.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.0K
01:37Epigenetic Regulation
3.6K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.6K
03:03mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
01:22MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
01:22MicroRNAs
23.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K